Article · 27 Mar 2025
EditorialPublished 18 Mar 2022
Editorial Note on Plasma Cell Leukemia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Plasma Cell Leukemia (PCL) is a plasma cell dyscrasia, for example an infection including the harmful degeneration of a subtype of white platelets called plasma cells. It is the terminal stage and most forceful type of these dyscrasias, establishing 2%to 4% of all instances of plasma cell malignancies. PCL might present as essential plasma cell leukemia, for example in patients without earlier history of a plasma cell dyscrasia or as auxiliary plasma cell dyscrasia, for example in patients recently determined to have a background marked by its archetype dyscrasia, different myeloma [1]. The two types of PCL seem, by all accounts, to be unquestionably somewhat unmistakable from one another. In all cases, notwithstanding, PCL is a very genuine, dangerous, and remedially testing illness [2].
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 13 Mar 2024
The Impact of HDAC Inhibitor and Progenitor Cells in the Treatment of Plasma Cell Leukemia
Perspective · 29 Nov 2023
Primary Plasma Cell Leukemia: An Uncommon Cause of Severe Leukocytosis
Perspective · 10 Apr 2023
Prognosis Therapeutic Relapse Transplantation in Patients with Plasma Cell Leukemia
Editorial · 8 Sep 2022
The Impact of Plasma Cell Leukemia on Quality of Life
More from this journal
The newest in Journal of Leukemia.
Opinion · 30 Dec 2025
Acute Lymphoblastic Leukemia Management from Conventional Chemotherapy to Precision-Based Treatment Approaches
Opinion · 30 Dec 2025
Stem Cell Transplantation in the Era of Precision Medicine Molecular Insights Therapeutic Strategies and Clinical Applications
Perspective · 30 Dec 2025
The Evolving Landscape of Leukemia Advances in Molecular Biology Immunotherapy and Clinical Outcomes
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Leukemia
- SubjectHaematology
- BylineArticles whose byline prints “Cesar Alfredo Pena Ramos”

